Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1406 Neoplasms 1131 Prostatic Neoplasms 746 Lung Neoplasms 622 Colorectal Neoplasms 598 Carcinoma, Non-Small-Cell Lung 571 Carcinoma, Hepatocellular 416 Pancreatic Neoplasms 401 Leukemia, Myeloid, Acute 398 Stomach Neoplasms 356 Multiple Myeloma 327 Brain Neoplasms 313 Ovarian Neoplasms 309 Head and Neck Neoplasms 292 Neoplasm Metastasis 277 Precursor Cell Lymphoblastic Leukemia-Lymphoma 261 Rectal Neoplasms 255 Uterine Cervical Neoplasms 248 Recurrence 248 Melanoma 243 Esophageal Neoplasms 237 Glioblastoma 232 Squamous Cell Carcinoma of Head and Neck 230 Lymphoma 214 Sarcoma 209 Urinary Bladder Neoplasms 194 Colonic Neoplasms 192 Glioma 191 Triple Negative Breast Neoplasms 190 Hematologic Neoplasms 183

Interventions

Darbepoetin alfa 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × OTHER × Primary Care × Clear all

NCT07130487 2025-11-25

Project CARE: CAncer Risk Evaluation

Rutgers, The State University of New Jersey

Phase NA Recruiting

Primary Care

Data powered by HemOnc (CC BY 4.0) Colophon ⚡